Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GABA-based therapeutic approaches: GABAA receptor subtype functions
Udo Rudolph, H. Möhler
Current Opinion in Pharmacology (2005) Vol. 6, Iss. 1, pp. 18-23
Closed Access | Times Cited: 477

Showing 1-25 of 477 citing articles:

Hippocampal sharp wave‐ripple: A cognitive biomarker for episodic memory and planning
György Buzsáki
Hippocampus (2015) Vol. 25, Iss. 10, pp. 1073-1188
Open Access | Times Cited: 1591
The GABAergic deficit hypothesis of major depressive disorder
Bernhard Lüscher, Shen Qu, Nadia Sahir
Molecular Psychiatry (2010) Vol. 16, Iss. 4, pp. 383-406
Open Access | Times Cited: 809
Role of GABA in anxiety and depression
Allan V. Kalueff, David Nutt
Depression and Anxiety (2006) Vol. 24, Iss. 7, pp. 495-517
Open Access | Times Cited: 500
Molecular Targets for Antiepileptic Drug Development
Brian S. Meldrum, Michael A. Rogawski
Neurotherapeutics (2007) Vol. 4, Iss. 1, pp. 18-61
Open Access | Times Cited: 463
Neural bases for addictive properties of benzodiazepines
Kelly R. Tan, Matthew T. Brown, Gwenaël Labouèbe, et al.
Nature (2010) Vol. 463, Iss. 7282, pp. 769-774
Open Access | Times Cited: 369
Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects
Maarten van den Buuse
Schizophrenia Bulletin (2009) Vol. 36, Iss. 2, pp. 246-270
Open Access | Times Cited: 340
GABAA receptor diversity and pharmacology
H. Möhler
Cell and Tissue Research (2006) Vol. 326, Iss. 2, pp. 505-516
Open Access | Times Cited: 339
Hooked on benzodiazepines: GABAA receptor subtypes and addiction
Kelly R. Tan, Uwe Rudolph, Christian Lüscher
Trends in Neurosciences (2011) Vol. 34, Iss. 4, pp. 188-197
Open Access | Times Cited: 327
Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects
Rainer Rupprecht, Gerhard Rammes, Daniela Eser, et al.
Science (2009) Vol. 325, Iss. 5939, pp. 490-493
Closed Access | Times Cited: 314
Antiepileptic Drugs in Non-Epilepsy Disorders
Cecilie Johannessen Landmark
CNS Drugs (2008) Vol. 22, Iss. 1, pp. 27-47
Closed Access | Times Cited: 313
GABAA Receptor Subtypes: Therapeutic Potential in Down Syndrome, Affective Disorders, Schizophrenia, and Autism
Uwe Rudolph, Hanns Möhler
The Annual Review of Pharmacology and Toxicology (2013) Vol. 54, Iss. 1, pp. 483-507
Open Access | Times Cited: 294
Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
Charles F. Zorumski, Steven M. Paul, Douglas F. Covey, et al.
Neurobiology of Stress (2019) Vol. 11, pp. 100196-100196
Open Access | Times Cited: 282
Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics
Gijs Koopmanschap, Eelco Ruijter, Romano V. A. Orrù
Beilstein Journal of Organic Chemistry (2014) Vol. 10, pp. 544-598
Open Access | Times Cited: 236
Tests of unconditioned anxiety — Pitfalls and disappointments
A. Ennaceur
Physiology & Behavior (2014) Vol. 135, pp. 55-71
Closed Access | Times Cited: 229
Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders
Thomas D. Prévot, Etienne Sibille
Molecular Psychiatry (2020) Vol. 26, Iss. 1, pp. 151-167
Closed Access | Times Cited: 193
New epilepsy therapies in development
Pavel Klein, Rafal M. Kaminski, Matthias J. Koepp, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 682-708
Closed Access | Times Cited: 28
Chloride regulation in the pain pathway
Theodore J. Price, Fernando Cerveró, Michael S. Gold, et al.
Brain Research Reviews (2009) Vol. 60, Iss. 1, pp. 149-170
Open Access | Times Cited: 258
The Clustering of GABAAReceptor Subtypes at Inhibitory Synapses is Facilitated via the Direct Binding of Receptor α2 Subunits to Gephyrin
Verena Tretter, Tija C. Jacob, Jayanta Mukherjee, et al.
Journal of Neuroscience (2008) Vol. 28, Iss. 6, pp. 1356-1365
Open Access | Times Cited: 244
How can drug discovery for psychiatric disorders be improved?
Y. Agid, György Buzsáki, David M. Diamond, et al.
Nature Reviews Drug Discovery (2007) Vol. 6, Iss. 3, pp. 189-201
Closed Access | Times Cited: 237
Flavonoid modulation of GABAA receptors
Jane R. Hanrahan, Mary Chebib, Graham A.R. Johnston
British Journal of Pharmacology (2011) Vol. 163, Iss. 2, pp. 234-245
Open Access | Times Cited: 218
Behavioral and Neural Analysis of GABA in the Acquisition, Consolidation, Reconsolidation, and Extinction of Fear Memory
Steve R. Makkar, Shirley Q Zhang, Jacquelyn Cranney
Neuropsychopharmacology (2010) Vol. 35, Iss. 8, pp. 1625-1652
Open Access | Times Cited: 216
Prepulse inhibition and genetic mouse models of schizophrenia
Susan B. Powell, Xianjin Zhou, Mark A. Geyer
Behavioural Brain Research (2009) Vol. 204, Iss. 2, pp. 282-294
Open Access | Times Cited: 209
Interneurons in the basolateral amygdala
Jay Spampanato, Jai S. Polepalli, Pankaj Sah
Neuropharmacology (2010) Vol. 60, Iss. 5, pp. 765-773
Closed Access | Times Cited: 191
Structural Requirements for Eszopiclone and Zolpidem Binding to the γ-Aminobutyric Acid Type-A (GABAA) Receptor Are Different
Susan M. Hanson, Elaine V. Morlock, Kenneth A. Satyshur, et al.
Journal of Medicinal Chemistry (2008) Vol. 51, Iss. 22, pp. 7243-7252
Open Access | Times Cited: 187
Copper signaling in the mammalian nervous system: Synaptic effects
Eric D. Gaier, Betty Eipper, R.E. Mains
Journal of Neuroscience Research (2012) Vol. 91, Iss. 1, pp. 2-19
Open Access | Times Cited: 185
Page 1 - Next Page

Scroll to top